Safety, efficacy main concerns with Russia's COVID-19 vaccine: Nobel laureate Peter Doherty
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF). The vaccine has not been tested in Phase 3 or larger clinical trials.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Clinical Trials | COVID-19 | Epidemiology | Microbiology | Pharmaceuticals | Russia Health | Vaccines